The role of the heme oxygenase system in the metabolic syndrome

Current Pharmaceutical Design

Volumn 20, Issue 31, 2014, Pages 4970-4974

  Barbagallo, Ignazio ^a,b   Nicolosi, Anna ^a   Calabrese, Giorgio ^c   David, Sabrina ^d   Cimino, Sebastiano ^a   Madonia, Massimo ^e   Cappello, Francesco ^b,d,f  

^a UNIVERSITY OF CATANIA   (Italy)

^b Istituto EuroMediterraneo di Scienza e Tecnologia   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

^f Department of Veterinary Medical Sciences   (Switzerland)

Author keywords

Adiponectin; Heat shock proteins; Heme oxygenase; Insulin sensitivity; Metabolic syndrome

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; INSULIN; ADIPOCYTOKINE; HEME OXYGENASE;

ARTICLE; CARDIOMETABOLIC RISK; HUMAN; INSULIN SENSITIVITY; METABOLIC REGULATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN DEFECT; ENZYMOLOGY; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; ADIPOCYTE; CELL ORGANELLE; HEAT SHOCK RESPONSE; HOMEOSTASIS; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; SIGNAL TRANSDUCTION;

HEAT-SHOCK PROTEINS; HEME OXYGENASE-1; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MOLECULAR CHAPERONES;

EID: 84906216692     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131206103824     Document Type: Article

References (68)

1. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-375.
2. Corrado E, Rizzo M, Caccamo G, et al. Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. Int Angiol 2012; 31: 572-578.
3. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol 2005; 4: 198-203.
4. Rizzo M, Pernice V, Frasheri A, et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf) 2009; 70: 870-875.
5. Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit? Diabetes Care 2004; 27: 1011-1012.
6. Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol 2009; 46: 1-11.
7. Novo G, Cappello F, Rizzo M, et al. Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl Res 2011; 157: 285-292.
8. Rizzo M, Macario AJ, de Macario EC, et al. Heat shock protein-60 and risk for cardiovascular disease. Curr Pharm Des 2011; 17: 3662-3668.
9. Barbagallo I, Galvano F, Frigiola A, et al. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal 2013; 18: 507-521.
10. Barbagallo I, Marrazzo G, Frigiola A, Zappala A, Li Volti G. Role of carbon monoxide in vascular diseases. Curr Pharm Biotechnol 2012; 13: 787-796.
11. Haak J, Kregel KC. 1962-2007: a cell stress odyssey. Novartis Found Symp 2008; 291: 3-15; discussion 15-22, 137-40.
12. Macario AJ, Conway de Macario E. Molecular chaperones: multiple functions, pathologies, and potential applications. Front Biosci 2007; 12: 2588-2600.
13. Cappello F, Conway de Macario E, Marasa L, Zummo G, Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 2008; 7: 801-809.
14. Brocchieri L, Conway de Macario E, Macario AJ. hsp70 genes in the human genome: Conservation and differentiation patterns predict a wide array of overlapping and specialized functions. BMC Evol Biol 2008; 8: 19.
15. Shamovsky I, Nudler E. New insights into the mechanism of heat shock response activation. Cell Mol Life Sci 2008; 65: 855-861.
16. Merendino AM, Bucchieri F, Campanella C, et al. Hsp60 is actively secreted by human tumor cells. PLoS One 2010; 5: e9247.
17. Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005; 353: 1489-1501.
18. Macario AJ, Conway de Macario E. Chaperonopathies by defect, excess, or mistake. Ann N Y Acad Sci 2007; 1113: 178-191.
19. Macario AJ, Conway de Macario E. Chaperonopathies and chaperonotherapy. FEBS Lett 2007; 581: 3681-3688.
20. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, et al. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol 2009; 64: 321-327.
21. Sahebkar A, Pourghadamyari H, Moohebati M, et al. A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant-antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease. Clin Biochem 2011; 44: 1390-1395.
22. Sage AT, Holtby-Ottenhof S, Shi Y, et al. Metabolic syndrome and acute hyperglycemia are associated with endoplasmic reticulum stress in human mononuclear cells. Obesity (Silver Spring) 2012; 20: 748-755.
23. Li Volti G, Sacerdoti D, Di Giacomo C, et al. Natural heme oxygenase-1 inducers in hepatobiliary function. World J Gastroenterol 2008; 14: 6122-6132.
24. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988; 2: 2557-2568.
25. Cui W, Fu G, Wu H, Shen W. Cadmium-induced heme oxygenase-1 gene expression is associated with the depletion of glutathione in the roots of Medicago sativa. Biometals 2011; 24: 93-103.
26. Hu X, Wang J, Jiang H. Heme oxygenase-1: An important therapeutic target for protecting against myocardial ischemia and reperfusion injury. Int J Cardiol 2012.
27. Dennery PA, Visner G, Weng YH, et al. Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. Free Radic Biol Med 2003; 34: 124-133.
28. Neubauer JA, Sunderram J. Heme oxygenase-1 and chronic hypoxia. Respir Physiol Neurobiol 2012; 184: 178-185.
29. Ejima K, Perrella MA. Alteration in heme oxygenase-1 and nitric oxide synthase-2 gene expression during endotoxemia in cyclooxygenase-2-deficient mice. Antioxid Redox Signal 2004; 6: 850-857.
30. Hayoun D, Kapp T, Edri-Brami M, et al. HSP60 is transported through the secretory pathway of 3-MCA-induced fibrosarcoma tumour cells and undergoes N-glycosylation. FEBS J 2012; 279: 2083-2095.
31. De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 2011; 16: 235-249.
32. Campanella C, Bucchieri F, Merendino AM, et al. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One 2012; 7: e42008.
33. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
34. Kaneto H, Matsuoka TA, Katakami N, et al. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr Mol Med 2007; 7: 674-686.
35. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm 2010; 2010: 359732.
36. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 1994; 91: 5987-5991.
37. Henningsson R, Alm P, Ekstrom P, Lundquist I. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes 1999; 48: 66-76.
38. Ndisang JF, Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 2009; 296: E829-E841.
39. Ndisang JF, Lane N, Jadhav A. Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab 2009; 296: E1029-E1041.
40. Ndisang JF, Lane N, Jadhav A. Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 2008; 26: 1188-1199.
41. Cao J, Drummond G, Inoue K, et al. Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress. Int J Mol Sci 2008; 9: 2388-23406.
42. Nicolai A, Li M, Kim DH, et al. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 2009; 53: 508-515.
43. Ndisang JF, Jadhav A. The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am J Physiol Regul Integr Comp Physiol 2010; 298: R211-R223.
44. Csongradi E, Docarmo JM, Dubinion JH, Vera T, Stec DE. Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. Int J Obes (Lond) 2012; 36: 244-253.
45. Abraham NG, Rezzani R, Rodella L, et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 2004; 287: H2468-H2477.
46. Sacerdoti D, Olszanecki R, Li Volti G, et al. Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications. Curr Neurovasc Res 2005; 2: 103-111.
47. Ndisang JF, Lane N, Syed N, Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010; 151: 549-560.
48. Kaneto H, Nakatani Y, Kawamori D, et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 2006; 38: 782-793.
49. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
50. Cao J, Sodhi K, Puri N, et al. High fat diet enhances cardiac abnormalities in SHR rats: Protective role of heme oxygenase-adiponectin axis. Diabetol Metab Syndr 2011; 3: 37.
51. Bluher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009; 117: 241-250.
52. Lim SS, Sammak PJ, Borisy GG. Progressive and spatially differentiated stability of microtubules in developing neuronal cells. J Cell Biol 1989; 109: 253-263.
53. Vanella L, Kim DH, Asprinio D, et al. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 2010; 46: 236-243.
54. Barbagallo I, Vanella A, Peterson SJ, et al. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab 2010; 28: 276-288.
55. Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit 2009; 15: CR5-CR9.
56. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
57. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118: 2992-3002.
58. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
59. Nara N, Nakayama Y, Okamoto S, et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 2007; 282: 30794-803.
60. Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007; 117: 2877-2888.
61. Tabata M, Kadomatsu T, Fukuhara S, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009; 10: 178-188.
62. Huang JY, Chiang MT, Yet SF, Chau LY. Myeloid heme oxygenase-1 haploinsufficiency reduces high fat diet-induced insulin resistance by affecting adipose macrophage infiltration in mice. PLoS One 2012; 7: e38626.
63. Li M, Kim DH, Tsenovoy PL, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57: 1526-1535.
64. Sodhi K, Inoue K, Gotlinger KH, et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 2009; 331: 906-916.
65. Goodman AI, Chander PN, Rezzani R, et al. Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol 2006; 17: 1073-1081.
66. Seta F, Bellner L, Rezzani R, et al. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol 2006; 169: 1612-1623.
67. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60: 79-127.
68. Peterson SJ, Kim DH, Li M, et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 2009; 50: 1293-1304.